Emmanuelle Charpentier#908
$132.11▼ 17.15% 1W
Emmanuelle Charpentier
Science$AURA: 132.11
▼17.15%1W
Rank #908
Crowd: +0.0%
A scientist, Emmanuelle Charpentier is known for co-developing the CRISPR-Cas9 gene-editing technology.
Rank
#908
by $AURA
Price History
AURA News
Hover to see on chartEvents that have affected this price
Nobel Prize winners face new loss in bid for US CRISPR patents
Reuters2w ago
→
French microbiologist Emmanuelle Charpentier (L) and professor Jennifer Doudna of the U.S. pose for the media during a visit to a painting exhibition by children about the genome, at the San Francisco park in Oviedo
Reuters Connect2w ago
→
PTAB sides with Broad Institute over University of California on patent priority for use of CRISPR in eukaryotic cells
University of California, Berkeley2w ago
→
Therapeutic targeting for SARS-CoV-2 using CRISPR-Cas13
Doherty Institute3w ago
→
The revolutionary CRISPR-Cas9 gene editing tool
Umeå universitet3w ago
→
Emmanuelle Charpentier
Britannica4w ago
→
Statistics
24h Change-0.44%
1W Change-24.27%
Market Cap132.1M $AURA
All-Time High$AURA 427.13
All-Time Low$AURA 120.50
Crowd Sentiment+0.0%
Crowd Activity
Neutral, no crowd pressure
SellersNeutralBuyers
AURA traded (24h)+0 AURA
You might also like
More in Science
Jeremy Hansen
#1
746.07
▲ +2.31%
Reid Wiseman
#2
745.97
▲ +1.24%
Christina Koch
#12
620.46
▲ +3.56%
David Attenborough
#34
548.59
▼ -5.38%
Chris Hadfield
#111
412.95
▲ +6.96%
Brian Cox
#115
410.38
▼ -3.91%
Katalin Karikó
#178
355.92
▼ -8.87%
Victor Glover
#294
293.91
▲ +5.88%
Neil deGrasse Tyson
#311
287.22
▼ -10.72%
Jane Goodall
#339
277.96
▲ +12.73%
Peter Attia
#365
270.91
▲ +1.30%
Hannah Fry
#367
270.40
▼ -3.00%